Clarissa Desjardins

All filings by Clarissa Desjardins on record concern Clementia Pharmaceuticals Inc. Over a trading history stretching from 14 August 2017 to 17 April 2019, the count stands at 5 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 22 April 2019, reports a transaction of €13.5M in Clementia Pharmaceuticals Inc. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.